Evidence map›Paper›PMID 40770063›Full record

ArticleScientific reports2025

Mechanistic insights into the effects of Tris-2-butoxyethyl phosphate on multiple cancers using network toxicology and molecular docking.

Hongting Lu, Pengyu Huang, Bingqi Huang, Dongming He, Xinhuai Ou, Zhanyu Xu, Shikang Li

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongting Lu *Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, P. R. China.
Pengyu Huang *Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, P. R. China.
Bingqi HuangDepartment of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, P. R. China.
Dongming HeDepartment of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, P. R. China.
Xinhuai OuDepartment of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, P. R. China.
Zhanyu XuDepartment of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, P. R. China. xuzhanyu@sr.gxmu.edu.cn.
Shikang LiDepartment of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, P. R. China. shikangli@hotmail.com.

Funding

the Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation 2024GXNSFBA010032The National Natural Science Foundation of China (62461006) 62461006the Natural Science Foundation of Guangxi province(2022GXNSFAA035513) (2022GXNSFAA035513)the Youth Science Foundation of Guangxi Medical University GXMUYSF202420
6 · The paper itself

Abstract

This study investigates the potential mechanisms by which Tris(2-butoxyethyl) phosphate (TBEP) may contribute to the development and progression of human malignancies. Fourteen representative cancer types were selected to explore the molecular pathways through which TBEP may exert its effects. By integrating network toxicology, molecular docking, and molecular dynamics (MD) simulations, we elucidated the underlying mechanisms of TBEP-related carcinogenicity. Potential targets associated with these malignancies were identified using multiple databases, including Public Chemical Database (PubChem), Search Tool for Interacting Chemicals (STITCH), SwissTargetPrediction, The Human Gene Database (GeneCards), the Online Mendelian Inheritance in Man (OMIM), and the Therapeutic Target Database (TTD). Core targets were further screened through STRING analysis and visualized using Cytoscape software. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were then performed to characterize the biological functions and pathways involved Three-dimensional structures of the core target proteins were retrieved from the Protein Data Bank (PDB), optimized using PyMOL (version 3.0.3), and subjected to molecular docking with AutoDock Vina to assess their binding affinities with TBEP. The stability of the resulting protein-ligand complexes was validated through MD simulations using GROMACS 2022. Finally, the relevance of the identified cancer types was confirmed using The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases. Overall, our findings suggest that TBEP may promote cancer development by interacting with key targets such as SRC and CASP3 and modulating critical signaling pathways. This study provides new insights into the potential carcinogenic mechanisms of TBEP and offers a theoretical foundation for future prevention and therapeutic strategies.

Indexed as

Molecular Docking SimulationNeoplasmsOrganophosphatesHumansMolecular Dynamics SimulationOrganophosphatesCarcinogenicityMechanism of actionMolecular dockingNetwork toxicologyTris(2-butoxyethyl) phosphate

Identifiers

PMID40770063
PMCPMC12329048

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.